Moreover, Chen et al. reveal that gefitinib-resistant NSCLC cells release exosomes containing the elevated expression of lncRNA urothelial carcinoma-associated 1 (UCA1), which can promote gefitinib resistance by modulating FOSL2 expression via binding to miR-143 112. Here, FOSL2 is linked to non-small cell lung carcinoma.